That means this product is at phase 0 again.
Hardly. This product is essentially at the completion of Phase 2, and Phase 3 is only a few months away, perhaps as few as four, depending on when the FDA gives NDA status.
- Forums
- ASX - By Stock
- AVE
- oxymorphone trials begin
oxymorphone trials begin, page-42
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $580 | 200K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 29443702 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 52585197 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 29443702 | 0.002 |
21 | 39006742 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 52585197 | 27 |
0.004 | 34855707 | 16 |
0.005 | 16100418 | 10 |
0.006 | 19380067 | 10 |
0.007 | 5722471 | 6 |
Last trade - 13.20pm 18/09/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |